Tizanidne Hydrochloride Capsule
Product Images NDC 76420-231

5 FDA label images from Asclemed Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 76420-231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tiz01 (Tiz01)

Tiz01 (Tiz01)
Chemical structure diagram of Tizanidne Hydrochloride, the active ingredient in Tizanidne hydrochloride capsules. The structure shows a chlorinated heterocyclic compound with nitrogen and sulfur atoms and an attached piperazine ring.*
FDA Label Image

Tiz02 (Tiz02)

Tiz02 (Tiz02)
A line graph showing plasma Tizanidine concentration (ng/mL) over 24 hours after dosing, comparing 2x4 mg Tizanidine tablets and capsules administered with and without food. The x-axis represents hours from dosing, and the y-axis represents Tizanidine concentration in plasma.*
FDA Label Image

Tiz03 (Tiz03)

Tiz03 (Tiz03)
Line graph showing improvement in Ashworth Score over time (hours post-dose) for 16 mg tizanidine, 8 mg tizanidine, and placebo. The graph depicts mean improvement with error bars from 0 to 6 hours post-dose, indicating the effects of different doses on muscle spasticity compared to placebo.*
FDA Label Image

Tiz04 (Tiz04)

Tiz04 (Tiz04)
A chart depicting improvement in Ashworth Score over three time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). Data compares tizanidine (mean dose 28.8 mg) with placebo, showing greater improvement for tizanidine at each point, with error bars illustrating variability.*
FDA Label Image

Tiz05 (Tiz05)

Tiz05 (Tiz05)
Labels for Tizanidine HCl Capsules, 6 mg, packaged by Enovachem Pharmaceuticals and distributed by Ascend Laboratories, LLC. The image shows three labels for quantities of 30, 60, and 90 capsules, each displaying the NDC numbers 76420-231-30, 76420-231-60, and 76420-231-90 respectively. Labels include product details, barcodes, a caution about prescription use, and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.